Aurigene Pharmaceutical Services Limited is a leading contract research, development and manufacturing organization (CDMO). With a strong legacy of services in discovery, development and manufacturing we are ideally positioned to serve global pharma and specialty companies worldwide.
Our endeavor is to help accelerate the journey from laboratory to market by providing access to our capabilities, knowledge and experience. Our team of highly qualified and experienced scientists and engineers backed by the state-of-the-art infrastructure, work relentlessly for the success of our clients.
Our integrated service offerings range from discovery chemistry, discovery biology, custom development and manufacturing of clinical compounds to enable your IND/NDA fillings and commercial contract manufacturing. Our discovery and development services are offered from world-class R&D centers situated in India. This is supported by scale-up and commercial manufacturing facilities in India, UK, Mexico and the United States.
We provide a wide range of discovery services for large molecules and Cell & Gene Therapy (CGT) from our state-of-the-art facility located in Hyderabad, India. At the core of our large molecule discovery services is a talented team of scientists experienced in the design and delivery of a range of advanced therapeutic modalities such as Antibodies, Proteins, CGT, mRNA.
Aurigene Pharmaceutical Services is rapidly positioning itself to provide end-to-end integrated development and manufacturing offerings in traditional and advanced drug modalities. Our mAb and protein therapeutics development is supported by in-house physiochemical and bio analytical development. We have a state-of-the-art cGMP viral vector manufacturing facility being commissioned. Our manufacturing services cater to both GMP and non-GMP manufacturing for preclinical development as well as GMP operations to support clinical or commercial needs for any recombinant protein expressed in suspension mammalian culture or E.coli. We have technological flexibility in both stainless steel and single-use bioreactor systems, as well as ability to undertake alternating tangential flow for commercial scale manufacturing.
We undertake an integrated approach to our quality management system that enables greater flexibility and leverage pan – organization experience in managing regulatory audits.
While accelerating the R&D programs of our clients, we keep sustainability, quality, environment, health and safety (EHS) at the forefront of everything we do
Our endeavor is to help accelerate the journey from laboratory to market by providing access to our capabilities, knowledge and experience. Our team of highly qualified and experienced scientists and engineers backed by the state-of-the-art infrastructure, work relentlessly for the success of our clients.
Our integrated service offerings range from discovery chemistry, discovery biology, custom development and manufacturing of clinical compounds to enable your IND/NDA fillings and commercial contract manufacturing. Our discovery and development services are offered from world-class R&D centers situated in India. This is supported by scale-up and commercial manufacturing facilities in India, UK, Mexico and the United States.
We provide a wide range of discovery services for large molecules and Cell & Gene Therapy (CGT) from our state-of-the-art facility located in Hyderabad, India. At the core of our large molecule discovery services is a talented team of scientists experienced in the design and delivery of a range of advanced therapeutic modalities such as Antibodies, Proteins, CGT, mRNA.
Aurigene Pharmaceutical Services is rapidly positioning itself to provide end-to-end integrated development and manufacturing offerings in traditional and advanced drug modalities. Our mAb and protein therapeutics development is supported by in-house physiochemical and bio analytical development. We have a state-of-the-art cGMP viral vector manufacturing facility being commissioned. Our manufacturing services cater to both GMP and non-GMP manufacturing for preclinical development as well as GMP operations to support clinical or commercial needs for any recombinant protein expressed in suspension mammalian culture or E.coli. We have technological flexibility in both stainless steel and single-use bioreactor systems, as well as ability to undertake alternating tangential flow for commercial scale manufacturing.
We undertake an integrated approach to our quality management system that enables greater flexibility and leverage pan – organization experience in managing regulatory audits.
While accelerating the R&D programs of our clients, we keep sustainability, quality, environment, health and safety (EHS) at the forefront of everything we do
BIO DOUBLE HELIX SPONSORS
BIO HELIX SPONSORS
